Oxford Cancer

oxfordcancer.bsky.social

09 June 2026 16:20

Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer. 👏 www.cancer.ox.ac.uk/news/first-t...

EACR - European Association for Cancer Research

helloeacr.bsky.social

09 June 2026 16:20

Kairbaan Hodivala-Dilke presenting the @embo.org Keynote Lecture earlier today at #EACR2026!

Becki Lee

beckilee.bsky.social

22 May 2026 07:07

4/5 Key finding #3: longitudinal ctDNA monitoring provided early signals of both treatment response and resistance, often before radiological changes were seen. 📈

Becki Lee

beckilee.bsky.social

22 May 2026 07:07

Pleased to share results from the CAcTUS Phase II trial of ctDNA-guided therapy in BRAF-mutant advanced melanoma are now published! 🌵🧬 CAcTUS is the first melanoma trial to adapt treatment based on ctDNA testing. Read: www.nature.com/articles/s41...

Fabian Theis

fabiantheis.bsky.social

19 May 2026 09:46

50 today 🎉 Feeling a tad older, but mostly very grateful: to family, friends, colleagues, collaborators, and students for the journey so far! Huge thanks to my department for the amazing surprise reception today. You certainly know how to celebrate science & aging in style 😄🚀